THE LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) DEFINITION DISCRIMINATES RESPONDERS IN A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) TRIAL: POST-HOC ANALYSIS OF THE PHASE IIB MUSE TRIAL OF ANIFROLUMAB

被引：1

作者：

Morand, E. ^{[1
]}

Berglind, A. ^{[2
]}

Sheytanova, T. ^{[2
]}

Tummala, R. ^{[2
]}

Illei, G. ^{[3
]}

机构：

[1] Monash Univ, Melbourne, Vic, Australia

[2] AstraZeneca, Molndal, Sweden

[3] MedImmune LLC, Gaithersburg, MD USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷

关键词：

D O I：

10.1136/annrheumdis-2017-eular.2464

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0001

引用

页码：50 / 50

页数：1

共 50 条

[1] Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab
Morand, Eric F.
Trasieva, Teodora
Berglind, Anna
Illei, Gabor G.
Tummala, Raj
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (05) : 706 - 713
[2] Comment on: 'Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al
Isenberg, David
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (11)
[3] Utility of the Lupus Low Disease Activity State Definition in Discriminating Responders in the Phase IIb Muse Trial of Anifrolumab in Systemic Lupus Erythematosus
Morand, E.
Berglind, A.
Sheytanova, T.
Tummala, R.
Illei, G.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[4] Response to: 'Comment on: 'Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al' by Isenberg
Morand, Eric F.
Trasieva, Teodora
Berglind, Anna
Illei, Gabor
Tummala, Raj
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (11)
[5] Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS)
Enas I. Abdelhady
Mona Rabie
Rofaida A. Hassan
Clinical Rheumatology, 2021, 40 : 4553 - 4558
[6] Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS)
Abdelhady, Enas, I
Rabie, Mona
Hassan, Rofaida A.
CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4553 - 4558
[7] Association of Smoking and Cutaneous Manifestations in Systemic Lupus Erythematosus (SLE): Post-Hoc Results from Phase IIb Studies of Anifrolumab and Sifalimumab
Werth, Victoria P.
Illei, Gabor
Abreu, Gabriel
Wang, Liangwei
Greth, Warren
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[8] Low Lupus Disease Activity State (LLDAS) and Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus (SLE)
Meilleur, Shannon
Vinet, Evelyne
Bernatsky, Sasha
Grenier, Louis-Pierre
Kalache, Fares
Pineau, Christian
JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1125 - 1125
[9] Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
Oon, Shereen
Huq, Molla
Golder, Vera
Ong, Pei Xuan
Morand, Eric F.
Nikpour, Mandana
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (05) : 629 - 633
[10] Achievement of Lupus Low Disease Activity State (LLDAS) in the Early Phase of Systemic Lupus Erythematosus Prevent Damage Accrual
Piga, Matteo
Floris, Alberto
Cappellazzo, Giulia
Mathieu, Alessandro
Cauli, Alberto
ARTHRITIS & RHEUMATOLOGY, 2017, 69

← 1 2 3 4 5 →